Completed PHASE3 INTERVENTIONAL 3-arm NCT02249767

Bioequivalence Study of Tretinoin Gel 0.05% to Brand Tretinoin Gel

Sponsor: Spear Pharmaceuticals

Conditions Acne

Interventions Tretinoin

Updated 9 times since 2017 Last updated: Jan 24, 2020 Started: Nov 30, 2013 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Acne, this trial is completed. The trial is conducted by Spear Pharmaceuticals and has accumulated 9 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Mar 2020 — Jan 2021 [monthly]

Completed PHASE3
Feb 2020 — Mar 2020 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

Oct 2018 — Feb 2020 [monthly]

Completed PHASE3
Jun 2018 — Oct 2018 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Spear Pharmaceuticals

Data source: Spear Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.